Medication Disclosure: Inform your doctor about any supplements, medications, or B12 injections you are taking, as these can influence results
Tirzepatide is a dual GIP/GLP-1 receptor agonist, the first of its kind, developed by Eli Lilly, activating both pathways simultaneously
Serving Size: 2 Softgels Servings Per Container: 30 Amount Per Serving / %DV: Calories 10 / Setria L-Glutathione 500 mg / Proprietary Blend (from Sunflower Oil and Lecithin) 350 mg / Daily Value not established
The Onboarding Sequence: Identity & Consent: Secure verification and HIPAA data release
It was launched in 2022 but is considered less effective than the blockbuster injectibles.India had the third largest number of people with obesity as of 2022, behind China and the US, according to a study in The Lancet, with numbers surging as junk food consumption becomes more commonplace